Search results for: Patricia Danzon
Filter search results
OHE Lunchtime Seminar: ‘Age, Utilities, and Self-Reported Health: Issues for HTA’
17 May 2016, 11:00pm
…are those of the authors. Patricia Cubi-Molla joined OHE in September 2015. Patricia’s main areas of research are: health-related quality of life measures, subjective well-being, cost-effectiveness thresholds, estimation of health-related…
OHE at HESG, AES and PROMs Summer 2018
15 June 2018
…Association Conference is “Sharing decisions: What changes are needed?”. The conference takes place 20-22 June in Las Palmas de Gran Canaria and will be attended by Patricia Cubi-Molla and Mikel…
Age, Utilities, and Self-Reported Health: Issues for HTA
28 June 2016
…May 2016 OHE’s Patricia Cubi-Molla presented an OHE Lunchtime Seminar on age, utilities and self-reported health. The aim of the research presented by Patricia was to explore the possible reasons…
Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research
7 February 2018
OHE’s Patricia Cubi-Molla and Koonal Shah, with Kristina Burström, propose a new framework for classifying experience in health valuation research. A new journal article by OHE’s Patricia Cubi-Molla and Koonal…
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
…for pharmaceuticals (European Commission, 1998; Danzon, 1998). Designing regulatory systems to promote competition in the off-patent sector is an important issue for all governments concerned with obtaining maximum value from…
Would Waiving COVID-19 Vaccines Patents Save Lives?
18 May 2021
…[online] Available at: https://static1.squarespace.com/static/562094dee4b0d00c1a3ef761/t/57d9c6ebf5e231b2f02cd3d4/1473890031320/UNSG+HLP+Report+FINAL+12+Sept+2016.pdf . Danzon, P., Towse, A. and Mestre‐Ferrandiz, J., 2015. Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context. Health Economics, 24(3), pp.294–301. https://doi.org/10.1002/hec.3021. Chalkidou,…
Around the World in HTAs
…Huseyin Yildirim, Dilek Sernur Eminoğulları, Dr Tuba Saygın Avşar, and Patricia Cubi-Molla take us to Türkiye. 18 October 2023 Around The World in HTAs: Greece – Late but with an…
ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?
6 June 2022
…inclusion of the patient perspective throughout the process of gene therapy development, suggesting that this would improve the shared decision-making process. Finally, Patricia Dorling (Senior Director at Pfizer) took us…